Difference between revisions of "Fibrinogen gamma chain (TG2)"
m |
m |
||
| (5 intermediate revisions by one other user not shown) | |||
| Line 1: | Line 1: | ||
{| class="toccolours" border="1" style="float: left; clear: right; margin: 0 0 1em 1em; border-collapse: collapse;" | {| class="toccolours" border="1" style="float: left; clear: right; margin: 0 0 1em 1em; border-collapse: collapse;" | ||
| − | ! | + | ! {infobox header}| '''{{PAGENAME}}''' |
|- | |- | ||
| − | | align="center" colspan="2" bgcolor="#ffffff" | [[Image: | + | | align="center" colspan="2" bgcolor="#ffffff" | [[Image:Fibrinogen.JPG|200px|{{PAGENAME}}]] |
|- | |- | ||
| Substrate peptide name | | Substrate peptide name | ||
| Line 23: | Line 23: | ||
|- | |- | ||
| Reactive glutamines | | Reactive glutamines | ||
| − | | Q398 | + | | [[TG2 reactive residues (Fibrinogen gamma)|Q398]] |
|- | |- | ||
| Reactive lysines | | Reactive lysines | ||
| Line 46: | Line 46: | ||
|- | |- | ||
| Notes | | Notes | ||
| − | | | + | | [[Minor TG2 reactive residues (Fibrinogen gamma)|Q144, Q195, Q239, Q311]] are minor substrate sites considering modification by TG2 |
|- | |- | ||
| − | | | + | | {infobox header} | |
|- | |- | ||
|} | |} | ||
[[Category:Tissue transglutaminase|*]] | [[Category:Tissue transglutaminase|*]] | ||
Latest revision as of 11:37, 10 March 2015
| Fibrinogen gamma chain (TG2) | |
|---|---|
| |
| Substrate peptide name | Fibrinogen gamma chain |
| Synonyms | - |
| Determination type | In vitro |
| Source | Homo sapiens |
| Subcellular localization | Extracellular; plasma |
| Swissprot ID | P02679 |
| Reactive glutamines | Q398 |
| Reactive lysines | K406 |
| Substrate sequence | TIGEGQQHHLGGAKQVRPE |
| Structure | 1FID |
| Surface accessibility | ASAView pdf
ASAView txt |
| Disorder prediction | IUPred |
| Reference | PMID:2902081 |
| Notes | Q144, Q195, Q239, Q311 are minor substrate sites considering modification by TG2 |
